741.    Balch CM, Morton DL, Gershenwald JE, McMasters KM, Nieweg OE, Powell B, Ross MI, Sondak VK, Thompson JF: Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol 2009;60:872-875.

742.    Beasley GM, Kroon HM, Ross MI, Kam PC, Thompson JF: Isolated limb infusion for melanoma. in Balch CM, Houghton AN, Sober AJ, et al. (eds): Cutaneous Melanoma.  St Louis: Quality Medical Publishing, 2009, 541-553.

743.    Becker TM, Haferkamp S, Dijkstra MK, Scurr LL, Frausto M, Diefenbach E, Scolyer RA, Reisman DN, Mann GJ, Kefford RF, Rizos H: The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. Mol Cancer 2009;8:4.

744.    Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V, Larue L, Pritchard C, Marais R: Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 2009;15:294-303.

745.    Gershenwald JE, Balch CM, Soong SJ, Thompson JF: Prognostic factors and natural history of melanoma. in Balch CM, Houghton AN, Sober AJ, et al. (eds): Cutaneous Melanoma.  St Louis: Quality Medical Publishing, 2009, 16-64.

746.    Gershenwald JE, Thompson JF, Mozzillo N, Balch CM: Intraoperative mapping and sentinel node technology in patients with melanoma. in Balch CM, Houghton AN, Sober AJ, et al. (eds): Cutaneous Melanoma.  St Louis: Quality Medical Publishing, 2009, 415-446.

747.    Haferkamp S, Scurr LL, Becker TM, Frausto M, Kefford RF, Rizos H: Oncogene-Induced Senescence Does Not Require the p16(INK4a) or p14ARF Melanoma Tumor Suppressors. J Invest Dermatol 2009.

748.    Hare D, Burger F, Austin C, Fryer F, Grimm R, Reedy B, Scolyer RA, Thompson JF, Doble P: Elemental bio-imaging of melanoma in lymph node biopsies. Analyst 2009;134:450-453.

749.    Kroon HM, Lin DY, Kam PC, Thompson JF: Major Amputation for Irresectable Extremity Melanoma After Failure of Isolated Limb Infusion. Ann Surg Oncol 2009.

750.    Kroon HM, Lin DY, Kam PC, Thompson JF: Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma. Cancer 2009;115:1932-1940.

751.    Kroon HM, Lin DY, Kam PC, Thompson JF: Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma. Ann Surg Oncol 2009;16:1193-1201.

752.    Kroon HM, Lin DY, Kam PC, Thompson JF: Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma. Ann Surg 2009;249:1008-1013.

753.    Kroon HM, Moncrieff M, Kam PC, Thompson JF: Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients. Ann Surg Oncol 2009;16:1184-1192.

754.    Kroon HM, Thompson JF: Isolated limb infusion: A review. J Surg Oncol 2009.

755.    Kroon HM, Thompson JF, Hoekstra HJ: [Isolated infusion effective in melanoma and sarcoma. Good alternative for regional isolated cytostatic perfusion]. Ned Tijdschr Geneeskd 2009;153:508-514.

756.    Lam TK, Uren RF, Scolyer RA, Quinn MJ, Shannon KF, Thompson JF: False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res 2009;19:94-99.

757.    Martin RC, Murali R, Scolyer RA, Fitzgerald P, Colman MH, Thompson JF: So-called "malignant blue nevus": a clinicopathologic study of 23 patients. Cancer 2009.

758.    McMasters KM, Wong SL, Tyler DS, Balch CM, Thompson JF: Axillary and epitrochlear lymph node dissection for melanoma. in Balch CM, Houghton AN, Sober AJ, et al. (eds): Cutaneous Melanoma.  St Louis: Quality Medical Publishing, 2009, 447-456.

759.    Moncrieff MD, Spira K, Clark JR, Thompson JF, Clifford AR, O'Brien CJ, Shannon KF: Free flap reconstruction for melanoma of the head and neck: indications and outcomes. J Plast Reconstr Aesthet Surg 2009.

760.    Morton DL, Cochran AJ, Thompson JF, Sondak VK: The sentinel lymph node and regional melanoma metastases. in Balch CM, Houghton AN, Sober AJ, et al. (eds): Cutaneous Melanoma.  St Louis: Quality Medical Publishing, 2009, 373-386.

761.    Morton RL, Craig JC, Thompson JF: The role of surveillance chest X-rays in the follow-up of high-risk melanoma patients. Ann Surg Oncol 2009;16:571-577.

762.    Morton RL, Howard K, Thompson JF: The cost-effectiveness of sentinel node biopsy in patients with intermediate thickness primary cutaneous melanoma. Ann Surg Oncol 2009;16:929-940.

763.    Murali R, Hughes MT, Fitzgerald P, Thompson JF, Scolyer RA: Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma. Ann Surg 2009;249:641-647.

764.    Orlow I, Tommasi DV, Bloom B, Ostrovnaya I, Cotignola J, Mujumdar U, Busam KJ, Jungbluth AA, Scolyer RA, Thompson JF, Armstrong BK, Berwick M, Thomas NE, Begg CB: Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling. J Invest Dermatol 2009.

765.    Reynolds HM, Smith NP, Uren RF, Thompson JF, Dunbar PR: Three-dimensional visualization of skin lymphatic drainage patterns of the head and neck. Head Neck 2009.

766.    Sanki A, Scolyer RA, Thompson JF: Surgery for melanoma metastases of the gastrointestinal tract: indications and results. Eur J Surg Oncol 2009;35:313-319.

767.    Sober AJ, Shaw HM, Thompson JF: A history of melanoma: From Hunter to Milton. in Balch CM, Houghton AN, Sober AJ, et al. (eds): Cutaneous Melanoma.  St Louis: Quality Medical Publishing, 2009, 1-15.

768.    Spillane AJ, Cheung BL, Stretch JR, Scolyer RA, Shannon KF, Quinn MJ, Saw RP, McCarthy WH, Thompson JF: Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg 2009;249:473-480.

769.    Spillane AJ, Winstanley J, Thompson JF: Lymph node ratio in melanoma : a marker of variation in surgical quality? Cancer 2009.

770.    Stephens FO, Aigner KR, Allen-Mersh T, Hortobagyi G, Khayat D, Picksley SM, Sugarbaker P, Taguchi T, Thompson JF: Basics of Oncology.  Berlin Springer-Verlag, 2009.

771.    Stretch JR, Scolyer RA: Surgical Strategies and Histopathologic Issues in the Management of Lentigo Maligna. Ann Surg Oncol 2009.

772.    Thompson JF, Morton DL, Balch CM, Ross MI: Surgical excision of distant melanoma metastases. in Balch CM, Houghton AN, Sober AJ, et al. (eds): Cutaneous Melanoma.  St Louis: Quality Medical Publishing, 2009, 603-628.

773.    Uren RF, Thompson JF, Coventry BJ, Chatterton BE: Lymphoscintigraphy in patients with melanoma. in Balch CM, Houghton AN, Sober AJ, et al. (eds): Cutaneous Melanoma.  St Louis: Quality Medical Publishing, 2009, 387-414.

774.    Zhuang L, Scolyer RA, Lee CS, McCarthy SW, Cooper WA, Zhang XD, Thompson JF, Hersey P: Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology 2009;54:462-470.